16
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Oral isotretinoin is not associated with increased side-effects when prescribed to patients with less severe acne

&
Pages 211-213 | Received 07 Jan 1998, Accepted 24 Jun 1998, Published online: 12 Jul 2009

References

  • Cunliffe W J, van der Kerkhof P CU, Capito R, et al. Roaccutane treatment guidelines, results of an international study. Dermatology 1997; 194: 351–7
  • Lammer E J, et al. Retinoic acid embryopathy. New Engl J Med 1985; 313: 837–41
  • Layton A M. Long term safety and efficacy of oral isotretinoin in less severe acne. Retinoids Today Tomorrow 1996; 43: 6–7
  • Goulden V, Layton A M, Cunliffe W J. Current indications for isotretinoin as a treatment for acne vulgaris. Dermatology 1995; 190(4)284–7
  • Burke B M, Cunliffe W J. The assessment of acne vulgaris - the Leeds Technique. Br J Dermatol 1984; 111: 83–92
  • Hennes R, Mack A, Schell H, Vogt H J. 13-cis-Retinoic acid in conglobate acne. A follow up study of 14 trial centres. Arch Dermatol Res 1984; 276: 209–15
  • Jones D H, King K, Miller A J, Cunliffe W J. A dose response study of 13-cis-retinoic acid in acne vulgaris. Br J Dermatol 1983; 108: 333–43
  • Gatti S, Serrił F. Acute depression from isotretinoin. J Am Acad Dermatol 1991; 25(1, part)132

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.